A Wakui
- Molecular Biology top 10%
- Oncology top 5%
- Pulmonary and Respiratory Medicine top 10%
- Surgery
- Cancer Research top 10%
- Co-authors
- I NakaoK FutatsukiY. ShimadaRyunosuke KanamaruMakoto YoshinoTetsuya TaguchiN. OgawaYasushi Sakata
- Topics
- Cancer, Hypoxia, and Metabolism (22 papers)Cancer Treatment and Pharmacology (22 papers)Cancer therapeutics and mechanisms (17 papers)
- Cited by
- OncologyCancer ResearchPharmacology
- Partner nations
- JapanUnited StatesCanada
In The Last Decade
A Wakui
98 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 92
- Molecular Biology 719
- Oncology 708
- Pulmonary and Respiratory Medicine 371
- Surgery 245
- Cancer Research 202
Countries citing papers authored by A Wakui
This map shows the geographic impact of A Wakui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Wakui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Wakui more than expected).
Fields of papers citing papers by A Wakui
This network shows the impact of papers produced by A Wakui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Wakui. The network helps show where A Wakui may publish in the future.
Co-authorship network of co-authors of A Wakui
This figure shows the co-authorship network connecting the top 25 collaborators of A Wakui. A scholar is included among the top collaborators of A Wakui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Wakui. A Wakui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 9 | |
| 2 | 8 | |
| 3 | Zinc distribution in malignant tumors | 3 |
| 4 | 1 | |
| 5 | 8 | |
| 6 | 184 | |
| 7 | 18FDG Uptake of Human Cancers Heterotransplanted into Nude Mice-Comparison with the Degree of the Histological Differentiation | 0 |
| 8 | [Phase I clinical study of CPT-11. Research group of CPT-11]. | 58 |
| 9 | 11 | |
| 10 | 1 | |
| 11 | Mechanism of action of the synthetic imidazole compound YM 534 on human promyelocytic leukemia line HL-60 cells. | 1 |
| 12 | Inhibitory effects of prostaglandin A2 on c-myc expression and cell cycle progression in human leukemia cell line HL-60. | 42 |
| 13 | 14 | |
| 14 | [A model for the sensitivity determination of anticancer agents against human cancer using nude mice]. | 9 |
| 15 | 110 | |
| 16 | Changes in Growth and 18FDG(2-Deoxy-2-[18F]Fluoro-D-Glucose) Uptake of Rat Hepatomas by Anticancer Drugs | 4 |
| 17 | Changes of 2-Deoxy-2-Fluoro-[18F]-D-Glucose Uptake tn Rat Hepatomas by Anticancer Drugs | 1 |
| 18 | Studies on Myocardial Glucose Metaboltsm of Adriamycin-Administered Rats Using Positron-Emitting Radiopharmaceuticals | 1 |
| 19 | Combination chemotherapy for solid tumors using 5-fluorouracil, chromomycin-A, and prednisolone. | 1 |
| 20 | 1 |
About A Wakui
A Wakui is a scholar working on Cancer Research, Oncology and Toxicology, having authored 107 papers that have together received 1.5k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (22 papers), Cancer Treatment and Pharmacology (22 papers) and Cancer therapeutics and mechanisms (17 papers). The work is most often cited by research in Oncology (708 citations), Cancer Research (202 citations) and Pharmacology (110 citations). A Wakui has collaborated with scholars based in Japan, United States and Canada. Frequent co-authors include I Nakao, K Futatsuki, Y. Shimada, Ryunosuke Kanamaru, Makoto Yoshino, Tetsuya Taguchi, N. Ogawa, Yasushi Sakata, T Taguchi and Chikashi Ishioka. Their work appears in journals such as Journal of Clinical Oncology, Cancer and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.